Takeda M&A Summary
Takeda has acquired 22 companies, including 6 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 7 assets.
Takeda’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2020, when it sold Alinamin Pharmaceutical Co. to The Blackstone Group for $2.0B. Takeda has acquired in 6 different US states, and 5 countries. The Company’s most targeted sectors include life science (95%) and healthcare services (6%).
M&A Summary
-
M&A Total Activity25
- M&A Buy Activity18
- M&A Sell Activity7
- Total Sectors Invested 2
- Total Countries Invested 5
- M&A Buy/Sell Connections 16
Unlimited Searches
